<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>515-THROMBOLYTICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THROMBOLYTICS" code="B01AD" /></DRUG1>
<DRUG2>
<DRUG name="ACETYLSALICYLIC ACID" rxcui="1191">
<ATC code="A01AD05" />
<ATC code="B01AC06" />
<ATC code="B01AC56" />
<ATC code="C10BX01" />
<ATC code="C10BX02" />
<ATC code="C10BX04" />
<ATC code="M01BA03" />
<ATC code="N02BA01" />
<ATC code="N02BA51" />
<ATC code="N02BA71" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>515-THROMBOLYTICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THROMBOLYTICS" code="B01AD" /></DRUG1>
<DRUG2>
<CLASS name="PLATELET AGGREGATION INHIBITORS" code="B01AC-001" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>515-THROMBOLYTICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THROMBOLYTICS" code="B01AD" /></DRUG1>
<DRUG2>
<CLASS name="VITAMIN K ANTAGONISTS" code="B01AA-001" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>515-THROMBOLYTICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THROMBOLYTICS" code="B01AD" /></DRUG1>
<DRUG2>
<DRUG name="DEFIBROTIDE" rxcui="1311089">
<ATC code="B01AX01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Accrued risk of hemorrhage</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>515-THROMBOLYTICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THROMBOLYTICS" code="B01AD" /></DRUG1>
<DRUG2>
<CLASS name="LOW MOLECULAR WEIGHT HEPARINS AND RELATED DRUGS (CURATIVE DOSES AND/OR OLDER PATIENT)" code="B01AB-001" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>515-THROMBOLYTICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THROMBOLYTICS" code="B01AD" /></DRUG1>
<DRUG2>
<CLASS name="UNFRACTIONATED HEPARIN (CURATIVE DOSES AND/OR OLDER PATIENTS)" code="B01AB-003" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
</INTERACTIONS>
